𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carbohydrates in peptide and protein design

✍ Scribed by Knud J. Jensen; Jesper Brask


Publisher
Wiley (John Wiley & Sons)
Year
2005
Tongue
English
Weight
193 KB
Volume
80
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Monosaccharides and amino acids are fundamental building blocks in the assembly of nature's polymers. They have different structural aspects and, to a significant extent, different functional groups. Oligomerization gives rise to oligosaccharides and peptides, respectively. While carbohydrates and peptides can be found conjoined in nature, e.g., in glycopeptides, the aim of this review is the radical redesign of peptide structures using carbohydrates, particularly monosaccharides and cyclic oligosaccharides, to produce novel peptides, peptidomimetics, and abiotic proteins. These hybrid molecules, chimeras, have properties arising largely from the combination of structural characteristics of carbohydrates with the functional group diversity of peptides. This field includes de novo designed synthetic glycopeptides, sugar (carbohydrate) amino acids, carbohydrate scaffolds for nonpeptidal peptidomimetics of cyclic peptides, cyclodextrin functionalized peptides, and carboproteins, i.e., carbohydrate‐based proteinmimetics. These successful applications demonstrate the general utility of carbohydrates in peptide and protein architecture. Β© 2005 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 80: 747–761, 2005

This article was originally published online as an accepted preprint. The β€œPublished Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at [email protected]


πŸ“œ SIMILAR VOLUMES


Peptidic modulators of protein-protein i
✍ Mor Rubinstein; Masha Y. Niv πŸ“‚ Article πŸ“… 2009 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 161 KB πŸ‘ 2 views

## Abstract With the decline in productivity of drug‐development efforts, novel approaches to rational drug design are being introduced and developed. Naturally occurring and synthetic peptides are emerging as novel promising compounds that can specifically and efficiently modulate signaling pathwa